基于肠道菌群探讨热量限制防治肥胖相关代谢性疾病的研究进展

叶佳美

您当前的位置：

首页 >

文章列表页 >

基于肠道菌群探讨热量限制防治肥胖相关代谢性疾病的研究进展

更新时间：2025-09-11

- 基于肠道菌群探讨热量限制防治肥胖相关代谢性疾病的研究进展
- Research progress of caloric restriction in the prevention and treatment of obesity related metabolic diseases based on gut microbiota
- 重庆医科大学学报 2022年47卷第6期页码：676-682
- 作者机构：
  
  成都中医药大学养生康复学院,成都,610075
- 作者简介：
- 基金信息：
  
  国家自然科学基金面上资助项目(81973927)
- DOI：
  中图分类号： R589
- 纸质出版日期：2022
- 稿件说明：
移动端阅览
叶佳美. 基于肠道菌群探讨热量限制防治肥胖相关代谢性疾病的研究进展[J]. 重庆医科大学学报, 2022,47(6):676-682.

Ye Jiamei. Research progress of caloric restriction in the prevention and treatment of obesity related metabolic diseases based on gut microbiota[J]. Journal of chongqing medical university, 2022, 47(6): 676-682.
叶佳美. 基于肠道菌群探讨热量限制防治肥胖相关代谢性疾病的研究进展[J]. 重庆医科大学学报, 2022,47(6):676-682. DOI：

Ye Jiamei. Research progress of caloric restriction in the prevention and treatment of obesity related metabolic diseases based on gut microbiota[J]. Journal of chongqing medical university, 2022, 47(6): 676-682. DOI：

摘要

肥胖及其相关代谢性疾病已成为全球范围内严重影响人类健康的疾病。研究发现，菌群紊乱引起条件致病菌和有害细菌代谢产物增多，参与肥胖相关代谢性疾病的发生发展。饮食是影响肠道菌群的关键因素之一。已有大量证据表明，作为饮食干预方式之一，热量限制可明显改善肥胖、糖尿病、非酒精性脂肪肝等代谢性疾病的症状，而肠道菌群可能是其作用靶点之一。本文从肥胖、糖尿病和非酒精性脂肪肝病的肠道菌群改变、热量限制对3种代谢性疾病的治疗效果以及肠道菌群在其中的介导作用3方面进行综述。

Abstract

Obesity related metabolic diseases seriously affect human health all over the world. It's found that the disorder of gut microbiota leads to the increase of conditional pathogenic bacteria and harmful bacterial metabolites

which is involved in the occurrence and development of obesity related metabolic diseases. Diet is one of the important factors affecting gut microbiota. Caloric restriction as one of dietary intervention

a lot of evidence have proven that it can significantly improve the symptoms of metabolic diseases such as obesity

diabetes and nonalcoholic fatty liver disease. Gut microbiota may be one of its targets. Therefore

this paper reviews from such following three aspects as the changes of gut microbiota in obesity

diabetes and nonalcoholic fatty liver disease

the therapeutic effect of caloric restriction on these three metabolic diseases and the mediating role of gut microbiota in the process.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

锌α2 糖蛋白与胰岛素抵抗相关疾病关系的研究进展

亲代代谢异常对子代代谢的影响及机制

大柴胡汤缓解葡聚糖硫酸钠诱导的溃疡性结肠炎及肝损伤并与其对小鼠肠道菌群的调控作用相关

GLP-1受体激动剂类药物在肥胖治疗中的研究现状

代谢相关脂肪性肝病对高血压患者冠心病发生的影响